Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NEOGENOMICS INC | Chief Financial Officer | Stock Option (Right to Buy) | 77.9 K | $3.42 M | $43.95 | May 11, 2024 | Direct |
NEOGENOMICS INC | Chief Financial Officer | Common Stock | 149 K | $2.21 M | $14.86 | May 11, 2024 | Direct |
Privia Health Group, Inc. | EVP, CFO and CAO | Common Stock, $0.01 par value per share | 61.3 K | $1.47 M | $24.00 | Jan 5, 2022 | Direct |
NEOGENOMICS INC | Chief Financial Officer | Performance Stock Unit | 46.6 K | $693 K | $14.86 | May 11, 2024 | Direct |
NEOGENOMICS INC | Chief Financial Officer | Restricted Stock Unit | 26 K | $387 K | $14.86 | May 11, 2024 | Direct |
Privia Health Group, Inc. | EVP, CFO and CAO | Stock Option (Right to Purchase) | 235 K | Jan 5, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NEO | NEOGENOMICS INC | May 11, 2024 | 4 | -$47.1 K | 4 | May 14, 2024 | Chief Financial Officer |
NEO | NEOGENOMICS INC | Feb 23, 2024 | 3 | $0 | 4 | Feb 27, 2024 | Chief Financial Officer |
NEO | NEOGENOMICS INC | Dec 7, 2023 | 1 | $0 | 4 | Dec 11, 2023 | Chief Financial Officer |
NEO | NEOGENOMICS INC | May 11, 2023 | 3 | $0 | 4 | May 15, 2023 | Chief Financial Officer |
NEO | NEOGENOMICS INC | Dec 5, 2022 | 3 | $0 | 4 | Dec 7, 2022 | Chief Financial Officer |
NEO | NEOGENOMICS INC | Dec 5, 2022 | 0 | $0 | 3 | Dec 7, 2022 | Chief Financial Officer |
PRVA | Privia Health Group, Inc. | Jan 5, 2022 | 2 | $0 | 4 | Jan 7, 2022 | EVP, CFO and CAO |
PRVA | Privia Health Group, Inc. | Jan 5, 2022 | 0 | $0 | 3 | Jan 7, 2022 | EVP, CFO and CAO |